Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 13, 2016 9:30 AM - Nov 15, 2016 5:30 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

13th DIA Japan Annual Meeting 2016

[V5-S4] Recent Efforts for Realizing Personalized Medicine by Industry, Government and Academia

Session Chair(s)

Norisuke  Kawai, PhD

Norisuke Kawai, PhD

Senior Director, Head of Clinical Research

Pfizer R&D Japan G.K., Japan

To facilitate the development of personalized medicine, pharmaceutical companies, academic institutions, and regulatory agencies promote research and development in different ways. Pharmaceutical companies accelerate the evaluation of the relationship between the investigational drug and many biomarkers in the early phase of drug development and subsequently utilize this information in the later phases. Academic institutions endeavor to exploit novel adaptive designs, such as the umbrella design, to efficiently establish standard therapies. The Japan Agency for Medical Research and Development sponsors academic research in this field in collaboration with the pharmaceutical industry. This session will discuss the recent efforts of, and collaborations between, the government, industry, and academia in the field of personalized medicine.

Speaker(s)

Hideharu  Yamamoto, PhD

Challenges Faced Conducting Interim Biomarker Exploration in a PoC Study

Hideharu Yamamoto, PhD

Chugai Pharmaceutical Co., Ltd., Japan

Biostatistics Deputy Dept Manage, Biometrics Dept

Akihiro  Hirakawa, PhD

Utilization of Novel Trial Design for Personalized Medicine

Akihiro Hirakawa, PhD

Tokyo Medical and Dental University, Japan

Professor,Clinical Biostatistics,Graduate School of Medical and Dental Sciences

Yoshinori  Makino, PhD

AMED Efforts to the Realization of Personalized Medicine

Yoshinori Makino, PhD

National Cancer Center Hospital, Japan

Head of office,

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.